Cancer treatment
A recent study conducted at the University of California in San Francisco has highlighted the need for increased participation of Asian-American women in cancer prevention research. Investigators mailed surveys to primary care physicians in Northern California to assess their knowledge, attitudes, behaviors, and barriers concerning the participation of Asian-American women
Drugs
Recent research from the People's Republic of China has shed light on the role of MGr1-antigen in regulating tumor multidrug resistance (MDR) in gastric cancer cells. The study, published in the journal Tumor Biology, found that MGr1-Ag promotes the MDR phenotype of gastric cancer cells, decreases intracellular drug
Drugs
Researchers in France, Italy, and the United States have published groundbreaking studies that may lead to the development of more effective cancer therapies. The studies, published in reputable scientific journals, focus on novel ways to combat cancer, including the use of small interfering RNAs (siRNAs) and cyclooxygenase-2 (COX-2) inhibitors. Key
Cancer treatment
Accentia Biopharmaceuticals' subsidiary, Biovest International, has introduced a groundbreaking instrument, AutovaxID-C, at the Cancer Research Institute's meeting, opening new avenues in personalized medicine for cancer treatment. This automated hollow fiber cell culture instrument streamlines vaccine production, reducing the risk of cross-contamination and enabling the segregation of patient-specific
Cancer treatment
Recent research from the United States has shown great promise in using tumor-derived glucose-regulated protein 94 (GRP94/gp96) as a tumor vaccine. However, current protein-based approaches often require large quantities of tumor tissue, which may not be feasible. To address this challenge, scientists at Duke University explored the therapeutic efficacy
Drugs
Representatives from major research institutions and pharmaceutical companies worldwide showcased the critical role of Transgenomic's products and services in their groundbreaking research presentations at the American Association of Cancer Research annual meeting in Anaheim. Researchers utilized Transgenomic's tools for various applications, including mutational analysis, methylation status,
Drugs
Researchers at the University of Pittsburgh have identified protein phosphatases, specifically dual-specificity phosphatases (DSPases), as potential therapeutic targets for the treatment of cancer and Alzheimer's disease. The study, published in the Annual Review of Pharmacology and Toxicology, highlights the critical roles of DSPases in multiple signaling pathways and
Gastroenterology
Researchers in the United States have discovered that a combination of PTEN gene therapy and caffeine can synergistically suppress cell growth and induce apoptosis in colorectal cancer cells. This treatment, which involves the overexpression of the tumor suppressor PTEN gene and the use of caffeine, has been shown to be
Gastroenterology
Researchers from the University of Texas, M.D. Anderson Cancer Center have found that a combination of adenovirus-mediated transfer of the PTEN gene (Ad-PTEN) and caffeine can produce a synergistic therapeutic effect in colorectal cancer cells. This combination resulted in cell growth suppression and apoptosis in colorectal cancer cells, but
